Table 2.
ECM–Growth Factor Interaction | Example | Consequence |
---|---|---|
ECM binding to growth factor | Binding of FGF-2 and VEGF to heparin sulfate10,11 | Binding of growth factor to ECM facilitates/enhances signaling |
Binding of TGFβ1 to decorin, beta-glycan, biglycan, collagens, fibrillin5,7,12 | Sequestration and inactivation of TGFβ by matrix molecules | |
Binding of FGF to fibrin and fibrinogen6 | Protection of growth factor from degradation | |
Activation of growth factors from a latent form | TSP-1 activation of latent TGFβ8 | ECM component directly activates latent growth factor |
Stiffness of matrix activates TGFβ9,13 | Activation of TGFβ mediated by the stiff ECM through integrin sensing or enhanced stimulation via the PI3/Akt signaling pathway | |
Matrikine–growth factor receptor interaction | Tenascin-C and laminin bind to EGF receptors14 | Matrikine induced signaling through growth factor receptor binding |
ECM–integrin interaction-mediated growth factor signaling | Expression of αvβ3 is required for TNFα and VEGF induced angiogenesis15 | ECM modulation of integrin expression/activation modulates growth factor signaling |
ECM, extracellular matrix; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor; TGFβ, transforming growth factor beta; TSP, thrombospondins; EGF, epidermal growth factor; TNF, tumor necrosis factor.